| Trial ID: | L0457 |
| Source ID: | IRCT20180802040678N2
|
| Associated Drug: |
Piperine
|
| Title: |
Investigation of the effect of piperine supplement on anthropometric indices, ultrasonographic findings, biochemical parameters and quality of life in patients with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: Administration of Piperine 5mg supplement daily for three months. Intervention 2: Control group: Administration of placebo for three months.
|
| Outcome Measures: |
Fattly Liver Grading. Timepoint: Before and after intervention. Method of measurement: Ultrasonography.;Quality of Life. Timepoint: Before and after intervention. Method of measurement: SF-36, CLDQ, and Disease Symptom Index 2.0 questionnaires.;Anthropometric indices. Timepoint: Before and after intervention. Method of measurement: Body weight and Body Mass Index.;Biochemical parameters. Timepoint: Before and after intervention. Method of measurement: Aspartate Aminotransferase, Alanine Aminotransferase, Alkaline Phosphatase, Bilirubin Total and Direct, Fasting Blood Suger, Triglyceride, LDL, HDL, VLDL, Hs-CRP, Total Cholesterol, Albumin, Count Blood Cells, HbA1C, HOMA-IR, Fecal Calprotectin.nan
|
| Sponsor/Collaborators: |
Tabriz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 yearsno limit
|
| Phases: |
Phase 3
|
| Enrollment: |
64
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomizing by computer software, Blinding description: Participants-healthcare provider-data collectors.
|
| Start Date: |
13/08/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 October 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/41203
|
